Patent details

Basic Information

Publication number:

EP1406656

PCT Application Number:

PCT/US/2002/017790

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP027418490

PCT Publication Number:

WO/2002/100330

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF ADMINISTERING ANTI-TNF-ALPHA ANTIBODIES

French Title of Invention:

METHODES D'ADMINISTRATION D'ANTICORPS ANTI-TNF-ALPHA

German Title of Invention:

VERFAHREN ZUR VERABREICHUNG VON ANTI-TNF-ALPHA-ANTIKÖRPERN

SPC Number:

Dates

Filing date:

05/06/2002

Grant date:

09/01/2013

EP Publication Date:

09/01/2013

PCT Publication Date:

19/12/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/04/2004

EP B1 Publication Date:

09/01/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

05/06/2022

Renunciation date:

Revocation date:

26/11/2015

Annulment date:

Owner

From:

05/06/2002

 

 

Name:

AbbVie Biotechnology Ltd

Address:

Clarendon House 2, Church Street, HM 11 Hamilton, Bermuda (BM)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/04/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WEISS Roberta

Address:

United States (US)

2

Name:

KEMPENI Joachim

Address:

Germany (DE)

3

Name:

FISCHKOFF Steven, A.

Address:

United States (US)

Priority

Priority Number:

296961 P

Priority Date:

08/06/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/24;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

15/05/2015

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages